You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

FDA Statement Regarding the Use of Adeno-Associated Virus Reference Standard Materials

Human Gene Therapy Methods (Part B)

Mary Ann Liebert

Impact Factor: 4.2

Journal Homepage Submission guidelines

Restricted access

Letter

First published online February, 2015

FDA Statement Regarding the Use of Adeno-Associated Virus Reference Standard Materials

Volume 26, Issue 1

https://doi.org/10.1089/hgtb.2015.1501

Abstract

Get full access to this article

View all access options for this article.

References

Ayuso

, Blouin

, Lock

, et al. Manufacturing and characterization of a recombinant adeno-associated virus type 8 reference standard material. Hum Gene Ther, 2014; 25:977–987.

Lock

, Mcgorray

, Auricchio

, et al. Characterization of a recombinant adeno-associated virus type 2 reference standard material. Hum Gene Ther, 2010; 21:1273–1285.

Browse journal

Current issue OnlineFirst All issues